Jitomir J, Willoughby DS. Cassia cinnamon for the attenuation of glucose intolerance and insulin resistance resulting from sleep loss. J Med Food 2009;12:467–472.

Qian J, Block GD, Colwell CS, Matveyenko AV. Consequences of exposure to light at night on the pancreatic islet circadian clock and function in rats. Diabetes 2013;62:3469–3478.

Beccuti G, Pannain S. Sleep and obesity. Curr Opin Clin Nutr Metab Care 2011;14:402–412.

Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005;99:2008–2019.

Leproult R, Holmback U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014;63:1860–1869.

Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J Parenter Enteral Nutr 2011;35:14S–20S.

Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio MC. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 2012;32:637–647.

Pacha J, Sumova A. Circadian regulation of epithelial functions in the intestine. Acta Physiol (Oxf) 2013;208:11–24.

Mukherji A, Kobiita A, Ye T, Chambon P. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 2013;153:812–827.

Hoogerwerf WA. Biologic clocks and the gut. Curr Gastroenterol Rep 2006;8:353–359.

Summa KC, Voigt RM, Forsyth CB, Shaikh M, Cavanaugh K, Tang Y, et al. Disruption of the circadian clock in mice increases intestinal permeability and promotes alcoholinduced hepatic pathology and inflammation. PLoS One 2013;8:e67102.

Kyoko OO, Kono H, Ishimaru K, Miyake K, Kubota T, Ogawa H, et al. Expressions of tight junction proteins occludin and claudin-1 are under the circadian control in the mouse large intestine: implications in intestinal permeability and susceptibility to colitis. PLoS One 2014;9:e98016.

Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 2013;70:631–659.

Hongdan W, Shijian Q, Yanan S. Effect of Jiaotai Pill on serum cytokine in rats with insomnia induced by parachloroamphetamine acid. J Guangzhou Univ Tradit Chin Med (Chin) 2008;25:525–527.

Junping K, Yan W, Qingzheng W, Boyang Y, Yongqing Y. Studies on the sedative and hypnotic activities of Jiaotai Wan prepared by raw or wine-processed Coptidis Rhizoma. Pharmacol Clin Chin Mater Med (Chin) 2007;23:15–17.

Li Y. Clinical observation on application of Jiao Tai Pill on Shenque (CV 8) in treating insomnia. J Acupunct Tuina Sci 2010;8:35–37.

Chen G, Lu F, Xu L, Dong H, Yi P, Wang F, et al. The antidiabetic effects and pharmacokinetic profiles of berberine in mice treated with Jiao-Tai-Wan and its compatibility. Phytomedicine 2013;20:780–786.

Huang Z, Xu X, Lu F, Wang N, Chen G, Zhao Y, et al. Jiao Tai Wan attenuates hepatic lipid accumulation in type 2 diabetes mellitus. Evid Based Complement Alternat Med 2013;2013:567045.

Zou X, Huang W, Lu F, Fang K, Wang D, Zhao S, et al. The effects of Jiao-Tai-Wan on sleep, inflammation and insulin resistance in obesity-resistant rats with chronic partial sleep deprivation. BMC Complement Altern Med 2017;17:165.

Belobrajdic DP, King RA, Christophersen CT, Bird AR. Dietary resistant starch dose-dependently reduces adiposity in obesity-prone and obesity-resistant male rats. Nutr Metab 2012;9:93.

Liu J, Li F, Tang XD, Ma J, Mao M, Wu FZ, et al. Sini Powder Decoction alleviates mood disorder of insomnia by regulating cation-chloride cotransporters in hippocampus. Chin J Integr Med 2015; Nov 23. [Epub ahead of print]

Li HC, Yang YL, Ma M. Comparative study on treatment of somnipathy in patients with hypertension by traditional Chinese medicine and by estazolam. Chin J Integr Med 2007;27:123–126.

Wang ZZ, Wang YP, Yang B, Wan JP, Wang J. Clinical efficacies of treating refractory insomnia patients with estazolam plus alternating current magnetic field. Chin Med J 2012;125:3175–3176.

Roehrs T, Zorick F, Lord N, Koshorek GL, Roth T. Doserelated effects of estazolam on sleep of patients with insomnia. J Clin Psychopharmacol 1983;3:152–156.

Mavanji V, Teske JA, Billington CJ, Kotz CM. Partial sleep deprivation by environmental noise increases food intake and body weight in obesity-resistant rats. Obesity (Silver Spring) 2013;21:1396–1405.

Brager AJ, Ehlen JC, Castanon-Cervantes O, Natarajan D, Delisser P, Davidson AJ, et al. Sleep loss and the inflammatory response in mice under chronic environmental circadian disruption. PLoS One 2013;8:e63752.

Qian J, Scheer FA. Circadian system and glucose metabolism: implications for physiology and disease. Trends Endocrinol Metab 2016;27:282–293.

Li GX, Wang XM, Jiang T, Gong JF, Niu LY, Li N. Berberine prevents damage to the intestinal mucosal barrier during early phase of sepsis in rat through mechanisms independent of the NOD-like receptors signaling pathway. Eur J Pharmacol 2014;730:1–7.

Li HM, Wang YY, Wang HD, Cao WJ, Yu XH, Lu DX, et al. Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms. Acta Pharmacol Sin 2011;32:1364–1372.

Gu L, Li N, Gong J, Li Q, Zhu W, Li J. Berberine ameliorates intestinal epithelial tight-junction damage and downregulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis 2011;203:1602–1612.

Shan CY, Yang JH, Kong Y, Wang XY, Zheng MY, Xu YG, et al. Alteration of the intestinal barrier and GLP2 secretion in berberine-treated type 2 diabetic rats. J Endocrinol 2013;218:255–262.

Gong J, Hu ML, Fang K, Wang DK, Chen QJ, et al. Berberine attenuates intestinal mucosal barrier dysfunction in type 2 diabetic rats. Front Pharmacol 2017;8:42.